Bridge Neurotech and Butterfly Network Announce Partnership to Develop Fully Non-Invasive Brain-Computer Interface
Business Wire•06/10/2026•16:05 ET
0
Key Highlights
- ➤Butterfly Network (BFLY) signs multi-year Bridge Neurotech R&D agreement
- ➤Agreement includes Butterfly technology-access and development-milestone payments
- ➤Bridge commits to purchasing Butterfly hardware under the partnership
- ➤Bridge begins enrolling participants in its first human research study
- ➤Partnership targets fully non-invasive, ultrasound-based brain-computer interfaces
Expert Statements
Will Biederman, Founder and CEO of Bridge Neurotech
“We started Bridge because we believe the pieces are finally in place to make a non-invasive brain-computer interface possible, and ultrasound is central to that opportunity”
Will Biederman, Founder and CEO of Bridge Neurotech
“Butterfly has already brought ultrasound onto a fully integrated semiconductor chip, giving us a powerful and programmable foundation as we work toward real-time, non-invasive interaction with the brain.”
Joseph DeVivo, President, Chief Executive Officer and Chairman of Butterfly Network
“The BCI category holds enormous potential, from treating serious conditions to expanding human capabilities”
Joseph DeVivo, President, Chief Executive Officer and Chairman of Butterfly Network
“One of the most fundamental challenges will be expanding that potential to the masses. Innovators like Bridge are exploring surgery-free approaches to broaden access, and we’re proud our Ultrasound-on-Chip™ technology can help advance that pursuit.”
Bridge Neurotech and Butterfly Network Announce Partnership to Develop Fully Non-Invasive Brain-Computer Interface
Bridge will leverage Butterfly’s programmable Ultrasound-on-Chip™ technology to pursue real-time brain imaging and interaction using sound, without surgery or implants.
Get started
Create a free account to read the full story.